false
Catalog
Introduction to BrainScope Technology
Introduction to BrainScope Technology
Introduction to BrainScope Technology
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Brain injuries are not always easy to detect and can occur under a number of circumstances. The vast majority of head-injured patients receive a head CT, of which 91% are normal. This highlights the need for a decision support tool to help reduce unnecessary head CTs and the associated radiation exposure. Introducing BrainScope, an FDA-cleared, handheld medical device that enables clinicians to objectively assess head-injured patients. Your facility has selected BrainScope as a valuable and rapid triage tool to aid in ruling out the likelihood of a brain bleed, while also providing an objective assessment of concussion and concussion severity. Incorporating BrainScope into an emergency department's workflow has demonstrated a significant reduction in the use of head CTs, while decreasing patient length of stay and increasing patient satisfaction and safety. Any person 18 to 85 years old who has been injured within 72 hours with a Glasgow coma score of 13 to 15 is a candidate for a BrainScope assessment. BrainScope is suitable for use in patients on blood thinners, as well as patients that are alcohol or drug impaired. BrainScope rapidly collects EEG data using an easy-to-apply disposable headset placed on the patient's forehead. BrainScope measures profiles of brain electrical activity using the recorded EEG data and artificial intelligence-derived algorithms. With one EEG-based test, BrainScope can quickly provide objective results for both structural and functional brain injuries. Easy-to-interpret test results aid clinicians in ruling out brain bleed and determining concussion status quickly and accurately. The clinician can provide patients with a report containing actionable information when a follow-up is recommended. For pediatric patients, there is a digitized PCARN CT decision rule to aid in triage for acute structural injury, and for patients ages 13 to 17, there is an EEG-based test for objective assessment of concussion. BrainScope is designed for the easy, accurate, and objective assessment of your head-injured patients. We look forward to working with you and your team. For more information, visit brainscope.com.
Video Summary
BrainScope is a handheld medical device that helps clinicians assess head-injured patients. It reduces the need for unnecessary head CTs by providing an objective assessment of concussion and concussion severity. By incorporating BrainScope into emergency departments, there has been a significant reduction in the use of head CTs, decreased patient length of stay, and increased patient satisfaction and safety. BrainScope rapidly collects EEG data using a disposable headset, and with AI-derived algorithms, it provides objective results for both structural and functional brain injuries. The results are easy to interpret, aiding clinicians in ruling out brain bleed and determining concussion status. BrainScope is suitable for patients aged 18 to 85 who have been injured within 72 hours. For more information, visit brainscope.com.
Keywords
BrainScope
medical device
head-injured patients
concussion assessment
reduced head CTs
×
Please select your language
1
English